Literature DB >> 8712861

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.

C Vitali1, S Bombardieri, H M Moutsopoulos, J Coll, R Gerli, P Y Hatron, L Kater, Y T Konttinen, R Manthorpe, O Meyer, M Mosca, P Ostuni, R A Pellerito, Y Pennec, S R Porter, A Richards, B Sauvezie, M Schiødt, M Sciuto, Y Shoenfeld, F N Skopouli, J S Smolen, F Soromenho, M Tishler, M J Wattiaux.   

Abstract

OBJECTIVE: To assess the recently proposed preliminary criteria for the classification of Sjögren's syndrome (SS) in a multicentre European study of a new series of clinically defined cases.
METHODS: The criteria included six items: I = ocular symptoms; II = oral symptoms; III = evidence of keratoconjunctivitis sicca; IV = focal sialoadenitis by minor salivary gland biopsy; V = instrumental evidence of salivary gland involvement; VI = presence of autoantibodies. Each centre was asked to provide five patients with primary SS, five with secondary SS, five with connective tissue diseases (CTD) but without SS, and five controls (patients with ocular or oral features that may simulate SS). The preliminary six item classification criteria set was applied to both the SS patients and the non-SS controls, and the performance of the criteria in terms of sensitivity and specificity was tested.
RESULTS: The criteria set was tested on a total of 278 cases (157 SS patients and 121 non-SS controls) collected from 16 centres in 10 countries. At least four of the six items in the criteria set (limiting item VI to the presence of Ro(SS-A) or La(SS-B) antibodies) were present in 79 of 81 patients initially classified as having primary SS (sensitivity 97.5%), but in only seven of 121 non-SS controls (specificity 94.2%). When the presence of item I or II plus any two of items III-V of the criteria set was considered as indicative of secondary SS, 97.3% (71 of 73) of the patients initially defined as having this disorder and 91.8% (45 of 49) of the control patients with CTD without SS were correctly classified.
CONCLUSION: This prospective study confirmed the high validity and reliability of the classification criteria for SS recently proposed by the European Community Study Group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712861      PMCID: PMC1010105          DOI: 10.1136/ard.55.2.116

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

4.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.

Authors:  C Vitali; H M Moutsopoulos; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

8.  Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases.

Authors:  T E Daniels
Journal:  Arthritis Rheum       Date:  1984-02

9.  Sjögren's syndrome (Sicca syndrome): current issues.

Authors:  H M Moutsopoulos; T M Chused; D L Mann; J H Klippel; A S Fauci; M M Frank; T J Lawley; M I Hamburger
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

Review 10.  Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee.

Authors:  J F Fries; M C Hochberg; T A Medsger; G G Hunder; C Bombardier
Journal:  Arthritis Rheum       Date:  1994-04
View more
  88 in total

1.  Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.

Authors:  T Uhlig; T K Kvien; J L Jensen; T Axéll
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

2.  Sjögren's syndrome criteria.

Authors:  R Manthorpe
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 3.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 4.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

5.  Evaluation of the transforming growth factor-beta activity in normal and dry eye human tears by CCL-185 cell bioassay.

Authors:  Xiaofen Zheng; Cintia S De Paiva; Kavita Rao; De-Quan Li; William J Farley; Michael Stern; Stephen C Pflugfelder
Journal:  Cornea       Date:  2010-09       Impact factor: 2.651

Review 6.  Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome.

Authors:  Abhinandana Anantharaju; Mehdi Baluch; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 7.  The oral component of Sjögren's syndrome: pass the scalpel and check the water.

Authors:  Ava J Wu
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

8.  Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.

Authors:  M Watanabe; T Igishi; N Burioka; J Kurai; Y Fukuoka; K Kato; A Yamasaki; Y Hasegawa; R Okazaki; E Shimizu
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

9.  A possible role of galectin-9 in the pulmonary fibrosis of patients with interstitial pneumonia.

Authors:  Nobuhiro Matsumoto; Shigeki Katoh; Shigehisa Yanagi; Yasuji Arimura; Masatoshi Tokojima; Masaki Ueno; Mitsuomi Hirashima; Masamitsu Nakazato
Journal:  Lung       Date:  2013-01-16       Impact factor: 2.584

10.  Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients.

Authors:  B Marasini; M Gagetta; V Rossi; P Ferrari
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.